Unknown

Dataset Information

0

Identification of Candidate miRNA Biomarkers for Glaucoma.


ABSTRACT:

Purpose

Glaucoma, a leading cause of blindness worldwide, often remains undetected until irreversible vision loss has occurred. Treatments focus on lowering intraocular pressure (IOP), the only modifiable and readily measurable risk factor. However, IOP can vary and does not always predict disease progression. MicroRNAs (miRNAs) are promising biomarkers. They are abundant and stable in biological fluids, including plasma and aqueous humor (AqH). We aimed to identify differentially expressed miRNAs in AqH and plasma from glaucoma, exfoliation syndrome (XFS), and control subjects.

Methods

Plasma and AqH from two ethnic cohorts were harvested from glaucoma or XFS (often associated with glaucoma, n = 33) and control (n = 31) patients undergoing elective surgery. A custom miRNA array measured 372 miRNAs. Molecular target prediction and pathway analysis were performed with Ingenuity Pathway Analysis (IPA) and DIANA bioinformatical tools.

Results

Levels of miRNAs in plasma, a readily accessible biomarker source, correlated with miRNA levels in AqH. Twenty circulating miRNAs were at least 1.5-fold higher in glaucoma or XFS patients than in controls across two ethnic cohorts: miR-4667-5p (P = 4.1 × 10-5), miR-99b-3p (P = 4.8 × 10-5), miR-637 (P = 5.1 × 10-5), miR-4490 (P = 5.7 × 10-5), miR-1253 (P = 6.0 × 10-5), miR-3190-3p (P = 3.1 × 10-4), miR-3173-3p (P = 0.001), miR-608 (P = 0.001), miR-4725-3p (P = 0.002), miR-4448 (P = 0.002), and miR-323b-5p (P = 0.002), miR-4538 (P = 0.003), miR-3913-3p (P = 0.003), miR-3159 (P = 0.003), miR-4663 (P = 0.003), miR-4767 (P = 0.003), miR-4724-5p (P = 0.003), miR-1306-5p (P = 0.003), miR-181b-3p (P = 0.004), and miR-433-3p (P = 0.004). miR-637, miR-1306-5p, and miR-3159, in combination, allowed discrimination between glaucoma patients and control subjects (AUC = 0.91 ± 0.008, sensitivity 85.0%, specificity 87.5%).

Conclusions

These results identify specific miRNAs as potential biomarkers and provide insight into the molecular processes underlying glaucoma.

SUBMITTER: Hindle AG 

PROVIDER: S-EPMC6329203 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of Candidate miRNA Biomarkers for Glaucoma.

Hindle Allyson G AG   Thoonen Robrecht R   Jasien Jessica V JV   Grange Robert M H RMH   Amin Krishna K   Wise Jasen J   Ozaki Mineo M   Ritch Robert R   Malhotra Rajeev R   Buys Emmanuel S ES  

Investigative ophthalmology & visual science 20190101 1


<h4>Purpose</h4>Glaucoma, a leading cause of blindness worldwide, often remains undetected until irreversible vision loss has occurred. Treatments focus on lowering intraocular pressure (IOP), the only modifiable and readily measurable risk factor. However, IOP can vary and does not always predict disease progression. MicroRNAs (miRNAs) are promising biomarkers. They are abundant and stable in biological fluids, including plasma and aqueous humor (AqH). We aimed to identify differentially expres  ...[more]

Similar Datasets

| S-EPMC4007708 | biostudies-literature
| S-EPMC8405850 | biostudies-literature
| S-EPMC9112558 | biostudies-literature
| S-EPMC8389649 | biostudies-literature
| S-EPMC10634160 | biostudies-literature
| S-EPMC5929565 | biostudies-literature
| S-EPMC8579105 | biostudies-literature
| S-EPMC7076920 | biostudies-literature
| S-EPMC2829240 | biostudies-literature
2022-09-03 | GSE212623 | GEO